I surely agree that 100m EBITDA and 70-80m NPAT is likely. I hope the we start seeing a more positive outlook from here.
I note that we have almost completed year 2 of a 3-5 year turnaround plan and the heavy lifting has already been done.
From here I will continue to hold past $2 to see how much potential the company really has and enjoy the dividends.
I would speculate that within the next 12-18 months Crescent will be extolling the virtues of the company with a view to selling it at 15-20x NPAT or $2.5 to $3.
2016/17 Full Year Results, page-47
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CDD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $13.28M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 19.0¢ | 17.0¢ | $4.227K | 23.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49047 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 184 | 1 |
View Market Depth
| Last trade - 15.56pm 22/11/2024 (20 minute delay) ? |
| CDD (ASX) Chart |
